FNY Investment Advisers’s Lixte Biotechnology LIXT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-107,000
| Closed | -$129K | – | 1011 |
|
|
2025
Q1 | $129K | Buy |
107,000
+67,781
| +173% | +$81.7K | 0.08% | 192 |
|
|
2024
Q4 | $82K | Sell |
39,219
-32,419
| -45% | -$67.8K | 0.04% | 284 |
|
|
2024
Q3 | $139K | Buy |
71,638
+21,366
| +43% | +$41.5K | 0.07% | 202 |
|
|
2024
Q2 | $120K | Buy |
50,272
+47,272
| +1,576% | +$113K | 0.08% | 161 |
|
|
2024
Q1 | $10 | Sell |
3,000
-2,500
| -45% | -$8 | 0.01% | 442 |
|
|
2023
Q4 | $12K | Buy |
5,500
+500
| +10% | +$1.09K | 0.01% | 291 |
|
|
2023
Q3 | $12K | Buy |
+5,000
| New | +$12K | 0.01% | 347 |
|